What is SWAGW's health score?

Stran & Company, Inc. (SWAGW) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SWAGW's estimated fair value?

Based on our 5-year discounted cash flow model, Stran & Company, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SWAGW undervalued or overvalued?

Our model currently rates SWAGW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SWAGW... Refresh in a moment for the full analysis.

Stran & Company, Inc. (SWAGW)

Technology Fair Value High mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

30 Weak

Operating Trend

45 Mixed

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk

80 Strong

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.